Supreme Court Snubs Martin Shkreli’s Last-Ditch Bid to Avoid $64 Million Fine

<img width="1500" height="1000" src="https://gizmodo.com/app/uploads/2024/10/martin-shkreli-trial.jpg" alt="Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, arrives at federal court in the Brooklyn borough of New York, U.S., on Thursday, Aug. 3, 2017.">There were no generic alternatives to a lifesaving drug when Shkreli jacked up its price by more than $700 per pill in 2015.

https://gizmodo.com/supreme-court-snubs-martin-shkrelis-last-ditch-bid-to-avoid-64-million-fine-2000508300